Effect of Diacerein on Metabolic Control and Inflammatory Markers in Patients with Type 2 Diabetes Using Antidiabetic Agents: A Randomized Controlled Trial

Effect of Diacerein on Metabolic Control and Inflammatory Markers in Patients with Type 2 Diabetes Using Antidiabetic Agents: A Randomized Controlled Trial

Introduction. Studies have shown that T2DM is an inflammatory disease. Thus, the present study was aimed at evaluating whether diacerein could improve the metabolic and inflammatory profile among patients with T2DM under long-term treatment with glucose-lowering agents. Methods. This is a double-bli...

Full description

Saved in:

Bibliographic Details
Main Authors:	Glaucia S. Tres, Sandra C. Fuchs, Fabiana Piovesan, Patricia Koehler-Santos, Fernanda dos S. Pereira, Suzi Camey, Hugo K. Lisboa, Leila B. Moreira
Format:	Article
Language:	English
Published:	Wiley 2018-01-01
Series:	Journal of Diabetes Research
Online Access:	http://dx.doi.org/10.1155/2018/4246521
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparison Of Diacerein-Ginger With Diacerein Alone In Treating Knee Osteoarthritis
by: Mehtab Munir, et al.
Published: (2019-12-01)

Diacerein: Advantages and disadvantages
by: Andrei Evgenyevich Karateev
Published: (2014-12-01)

Diacerein in the treatment of chronic musculoskeletal pain
by: E. Yu. Polishchuk, et al.
Published: (2022-06-01)

Diacerein in the treatment of osteoarthritis in patients with comorbidity
by: E. P. Sharapova, et al.
Published: (2018-12-01)

Pleiotropic effects of diacerein in comorbid patients with osteoarthritis
by: I. B. Belyaeva, et al.
Published: (2022-08-01)

Efficacy and safety of diacerein in patients with knee osteoarthritis
by: L. I. Alekseeva, et al.
Published: (2017-09-01)

Diacerein for osteoarthritis: An open-label comparative trial
by: L. V. Luchikhina, et al.
Published: (2016-03-01)

Pharmacological therapy in patients with osteoarthritis and metabolic disorders: focus on diacerein
by: O.V. Kuryata, et al.
Published: (2025-03-01)

Flavonoids as Antidiabetic Agents, Challenges and Future Directions
by: Qamar Uddin Ahmed
Published: (2025-07-01)

DIACEREIN AS THE DRUG OF CHOICE IN THE THERAPY OF KNEE OSTEOARTHRITIS WITH SECONDARY RECURRENT SYNOVITIS
by: M. I. Udovika
Published: (2016-02-01)

An Injectable PEG/Diacerein‐Based Anti‐Inflammatory Hydrogel for Promoting Cartilage Regeneration: An In Vivo Study
by: Jing Mi, et al.
Published: (2025-05-01)

Antidiabetic agents as potential cytotoxic candidates for cancer therapy
by: Alnaser Raniah I., et al.
Published: (2025-06-01)

Effect of diacerein on the clinical course of osteoarthritis and endothelial dysfunction in patients with arterial hypertension
by: Yu. P. Uspenskiy, et al.
Published: (2021-06-01)

Efficacy and safety of the combined use of celecoxib, diacerein and a combination of glucosamine and chondroitin for the control of musculoskeletal pain associated with osteoarthritis and nonspecific back pain
by: A. E. Karateev, et al.
Published: (2023-10-01)

Synthesis of promising brominated flavonoids as antidiabetic and anti-glycation agents
by: Rita Hairani, et al.
Published: (2025-07-01)

Diacerein's Role in Alleviating Inflammation and Synovial Effusion in Knee Osteoarthritis: A Novel Therapeutic Approach
by: Saim Mahmood Khan, et al.
Published: (2025-03-01)

Use of diacerein for the treatment of large joint osteoarthritis (A review of literature and the author’s own experience)
by: Rimma Mikhailovna Balabanova
Published: (2015-09-01)

Design, synthesis, biological evaluation and computational studies of 4-Aminopiperidine-3, 4-dihyroquinazoline-2-uracil derivatives as promising antidiabetic agents
by: Ladan Baziar, et al.
Published: (2024-11-01)

Prospects for the Search for New Antidiabetic Agents Among Vanadium-containing Complex Compounds (Review)
by: A. I. Krasnova, et al.
Published: (2023-12-01)

Perioperative Considerations of Novel Antidiabetic Agents in Heart Failure Patients Undergoing Cardiac Surgery
by: Ashley Wang, et al.
Published: (2025-03-01)

Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents
by: Babiker Saad Almugadam, et al.
Published: (2020-01-01)

Development and Validation of Stability Indicating HPTLC Method for Determination of Diacerein and Aceclofenac as Bulk Drug and in Tablet Dosage Form
by: S. P. Gandhi, et al.
Published: (2012-01-01)

ESTIMATION OF DIACEREIN TOLERABILITY IN REAL CLINICAL PRACTICE: RESULTS OF THE RACADA (RETROSPECTIVE ASSESSMENT OF CLINICAL ASPECTS OF USING DIAFLEX IN OSTEOARTHRITIS)
by: A. E. Karateev, et al.
Published: (2015-04-01)

Exploring the Protective Effects of Traditional Antidiabetic Medications and Novel Antihyperglycemic Agents in Diabetic Rodent Models
by: Cosmin Gabriel Tartau, et al.
Published: (2025-05-01)

Natural Antidiabetic Agents: Insights into Ericaceae-Derived Phenolics and Their Role in Metabolic and Oxidative Modulation in Diabetes
by: Mihaela Popescu, et al.
Published: (2025-05-01)

Marine Fungal Metabolites as Potential Antidiabetic Agents: A Comprehensive Review of Their Structures and Enzyme Inhibitory Activities
by: Zimin Wang, et al.
Published: (2025-03-01)

Novel Quinoline- and Naphthalene-Incorporated Hydrazineylidene–Propenamide Analogues as Antidiabetic Agents: Design, Synthesis, and Computational Studies
by: Osama Alharbi, et al.
Published: (2024-12-01)

CADD based designing and biological evaluation of novel triazole based thiazolidinedione coumarin hybrids as antidiabetic agent
by: Anchal Sharma, et al.
Published: (2025-02-01)

Synthesis and In vitro Biological Evaluation of Quinolone-Based Hydrazones as Potential Antidiabetic Agents Targeting Key Metabolic Enzymes
by: Naik Jui Pravin, et al.
Published: (2025-07-01)

Heart failure outcomes in patients with type 2 diabetes mellitus: findings from the cardiovascular outcome trials of antidiabetes agents
by: Stefan D. Anker
Published: (2019-12-01)

Program Health with Agent: Protagonism and professional profile of nurses who acted as preceptors in the training of Community Health Agents and Endemic Disease Control Agents in Brazil
by: Luciana Barcellos Teixeira, et al.
Published: (2025-07-01)

Identification of petunidin from Chrysobalanus orbicularis Hook. F. (Chrysobalanaceae) as a potential antidiabetic agent: HPLC profiling and in silico validation
by: Lisa Ilobekemen Ekakitie, et al.
Published: (2025-08-01)

Changes in Iron Metabolism and Oxidative Status in STZ-Induced Diabetic Rats Treated with Bis(maltolato) Oxovanadium (IV) as an Antidiabetic Agent
by: Cristina Sánchez-González, et al.
Published: (2014-01-01)

Computational screening for novel α-glucosidase inhibitory peptides from Chlamys nobilis adductor muscle as a potential antidiabetic agent
by: Haisheng Lin, et al.
Published: (2025-03-01)

Adherence to the treatment with oral antidiabetic medications in primary health care
by: Andréa Pereira da Silva, et al.
Published: (2015-06-01)

Adherence to the treatment with oral antidiabetic medications in primary health care
by: Andréa Pereira da Silva, et al.
Published: (2015-06-01)

The Antidiabetic Agent Sodium Tungstate Induces Abnormal Glycogen Accumulation in Renal Proximal Tubules from Diabetic IRS2-Knockout Mice
by: Romina Bertinat, et al.
Published: (2018-01-01)

Necessity of Baseline Diabetic Autonomic Neuropathy Screening to Start Cardiovascular Safety Outcome Trials: A Focus on Antidiabetic Agents and Autonomic Neurointegrity
by: Shambo Samrat Samajdar, et al.
Published: (2022-04-01)

ANTIDIABETIC ACTIVITY OF GUANIDINIUM SALT 2-AMINOPHENYLACETATE
by: E. V. Ponomarenko
Published: (2019-01-01)

Polyphenolic Compounds in Fabaceous Plants with Antidiabetic Potential
by: Lucia Guerrero-Becerra, et al.
Published: (2025-01-01)